The Universal Data Collection Surveillance System for Rare Bleeding Disorders

American Journal of Preventive Medicine

Volumn 38, Issue 4 SUPPL., 2010, Pages

  Soucie, J Michael ^a   McAlister, Sally ^a   McClellan, Ann ^a   Oakley, Meredith ^a   Su, Ying ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTHROPATHY; BLEEDING DISORDER; BLOOD DONOR; BODY WEIGHT; DATA BASE; HEALTH PROGRAM; HEALTH SURVEY; HEMOPHILIA; HUMAN; INFECTIOUS ARTHRITIS; INFORMATION PROCESSING; OUTCOME ASSESSMENT; PATIENT MONITORING; PATIENT SAFETY; RARE DISEASE; REVIEW; RISK FACTOR;

DATA COLLECTION; GEOGRAPHIC INFORMATION SYSTEMS; HEMORRHAGIC DISORDERS; HUMANS; POPULATION SURVEILLANCE; PUBLIC HEALTH INFORMATICS; RARE DISEASES; REGISTRIES; UNITED STATES;

EID: 77949453184     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amepre.2009.12.023     Document Type: Review

References (16)

1. Thacker S.B., and Berkelman R.L. Public health surveillance in the United States. Epidemiol Rev 10 (1988) 164-190
2. Larsson S.A., and Wiechel B. Deaths in Swedish hemophiliacs, 1957-80. Acta Med Scand 214 (1983) 199-206
3. Aledort L.M. Hemophilia: yesterday, today and tomorrow. Mt Sinai J Med 63 (1996) 225-235
4. Baker J.R., Crudder S.O., Riske B., Bias V., and Forsberg A. A model for a regional system of care to promote health and well-being for people with rare chronic genetic disorders. Am J Public Health 95 (2005) 1910-1916
5. Jason J., McDougal J.S., Holman R.C., et al., Hemophilia/AIDS Collaborative Study Group. Human T-lymphotropic retrovirus type III/lymphadenopathy-associated virus antibody: association with hemophiliacs' immune status and blood component usage. JAMA 253 (1985) 3409-3415
6. CDC. Blood safety monitoring among persons with bleeding disorders-U.S., May 1998-June 2002. MMWR Morb Mortal Wkly Rep 51 (2003) 1152-1154
7. Soucie J.M., Siwak E.B., Hooper W.C., Evatt B.L., Hollinger F.B., and Universal Data Collection Project Working Group. Human parvovirus B19 in young males with hemophilia A: associations with treatment product exposure and joint range-of-motion limitation. Transfusion 44 (2004) 1179-1185
8. Allain J.P., Thomas I., and Sauleda S. Nucleic acid testing for emerging viral infections. Transfus Med 12 (2002) 275-283
9. Wu C., Mason B., Jong J., et al. Parvovirus B19 transmission by a high-purity factor VIII concentrate. Transfusion 45 (2005) 1003-1010
10. Soucie J.M., Cianfrini C., Janco R.L., et al. Joint range of motion limitations among young males with hemophilia: prevalence and risk factors. Blood 103 (2004) 2467-2473
11. Ogden C.L., Carroll M.D., and Flegal K.M. High body mass index for age among U.S. children and adolescents, 2003-2006. JAMA 299 (2008) 2401-2405
12. Cromley E.K., and McLafferty S.L. GIS and public health (2002), The Guilford Press, New York
13. McClellan A.C., Soucie J.M., and Kulkarni R. Using geographical information systems (GIS) to examine associations between characteristics of males with hemophilia and geographic distance to hemophilia treatment centers (HTCs). Blood (ASH Annual Meeting Abstracts) 108 (Nov 2006) 3301
14. Manco-Johnson M.J., Abshire T.C., Shapiro A.D., et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Eng J Med 357 (2007) 535-544
15. Ashrani A.A., Key N.S., Soucie J.M., Duffy N., Forsyth A., Geraghty S., and Universal Data Collection Project Investigators. Septic arthritis in males with haemophilia. Haemophilia 14 (2008) 494-503
16. Metjian A.D., Wang C., Sood S.L., et al. Bleeding symptoms and laboratory correlation in patients with severe von Willebrand disease. Haemophilia 15 (2009) 918-925